Recently we have suggested to use m agnetolipo somes (liposomes loaded besides the drug with a magnetic particles) in the treatment of cancer (Babincova, 1993; Babincova and Babinec, 1995), and this approach has been shown to be feasible both in vitro (Viroonchatopan et al., 1995) and in vivo (Viroonchatopan et al., 1996) for treatment of hepatocellular carcinoma. In this case two advan tages of magnetoliposomes (MLs) became evi dent: a locally applied constant magnetic field is used to bind the MLs to the appropriate site (e.g. tumor) and subsequently release the drug at a given site by microwave radiation or a high-fre quency magnetic field (Babincova and Babinec, 1997). We look forward to finding an experimental op portunity to check our m ethods with a sick patient.
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